SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Memecoin on Cronos launched by the Cro Crow community

crow with knife

The $CAW cryptocurrency, also known as crow with knife, is trending as the community rallies behind its multi-chain functionality, bridging across $SOL, $BSC, $CRO, and $ETH (BASE) using Layerzero technology. Community members highlight its deflationary mechanisms and organic growth, while also mentioning potential staking opportunities. The focus remains on its unique branding and strong community engagement within the meme coin sector.

Cronos is an institutional-grade, high-performance, EVM-compatible Layer-1 blockchain built on the Cosmos SDK and integrated with the Inter-Blockchain Communication (IBC) protocol, designed as the backbone for open, compliant, and AI-accessible tokenized markets. It supports up to 60,000 transactions per second (TPS), 500ms block times, instant finality, and sub-$0.01 fees via Proof of Authority consensus.

Crypto.com Coin

Crypto.com Coin ($CRO) is trending as the community debates its potential, with some expressing frustration over its price action compared to other cryptocurrencies like $BNB. Discussions include speculation about market manipulation and the impact of partnerships, as well as potential catalysts like a Cronos ETF and the broader adoption of crypto. Meanwhile, the memecoin $CAW, aka crow with knife, is seeing increased interest across multiple chains including $CRO.

Bonk refers to a series of comic-style memes in which meme characters such as Doge and Cheems get hit on the head with bats, hammers and other heavy objects, accompanied by the “Bonk” sound effect and clipart. The original image that spawned the meme depicts a Shiba Inu, named Copper. Bonk brings this humor on-chain, transforming the classic meme into a tokenized digital movement powered by community and culture.

Copper Inu

Copper Inu ($COPPER) is trending amid community discussions about its chart patterns and potential for a breakout, particularly in relation to other tokens like $SOL and $BTC. Some users are pointing to its name as indicative of strength, while others express concerns about potential scams.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is trending as the community discusses potential staking opportunities and meme coin integrations within its ecosystem. Conversations highlight Solana's strong setup and positive trend, with some anticipating a potential move towards new highs. Community members are also closely watching various meme coins built on Solana, such as $CAW and $UPDOG.

Recall is a decentralized skill market for AI where communities fund, rank, and discover the AI solutions they need. Instead of corporations pushing one-size-fits-all AI, Recall flips the dynamic—communities signal demand, developers compete to deliver, and performance determines visibility.

Recall

RECALL CRYPTO is trending due to its recent ICO, with community members actively discussing its potential and current price action. High volume and new highs are fueling interest, though some caution against potential risks associated with new cryptocurrencies. The community is also comparing RECALL to other cryptocurrencies and exploring its potential within the broader crypto market.

Exxon Mobil Corp. engages in the exploration, development, and distribution of oil, gas, and petroleum products. It operates through the following segments: Upstream, Energy Products, Chemical Products, and Specialty Products. The Upstream segment organizes the exploration of crude oil and natural gas. The Energy Products segment includes fuels, aromatics, and catalyst and licensing. The Chemical Products segment offers petrochemicals. The Specialty Products segment provides finished lubricants, basestocks and waxes, synthetics, and elastomers and resins. The company was founded by John D. Rockefeller in 1882 and is headquartered in Spring, TX.

Exxon Mobil Corp.

Exxon Mobil Corp

Exxon Mobil is trending as the community discusses analyst ratings updates and anticipation for upcoming earnings. Some reports focus on the company's strategic moves in Guyana and the Permian Basin, while others highlight its cost-cutting initiatives. Option traders are actively positioning, reacting to technical indicators and potential price movements.

Fiserv, Inc. engages in the provision of financial services technology. It operates through the Merchant and Financial segments. The Merchant segment offers commerce-enabling products and services including merchant acquiring and digital commerce and mobile payment services, and security and fraud protection, stored-value, and pay-by-bank solutions to companies of all sizes. The Financial segment provides products and services such as processing of customer loan and deposit accounts, digital payments, and card transactions to financial institutions and corporate and public sector clients. The company was founded by Leslie M. Muma and George D. Dalton on July 31, 1984 and is headquartered in Milwaukee, WI.

Fiserv, Inc.

Fiserv is trending as investors assess its oversold condition after recent declines, with community members discussing potential catalysts for a reversal and debating whether it represents a value opportunity or a value trap. Discussions include the company's free cash flow, debt, and competitive position in payment processing, as well as analyst ratings and target prices. Call options are being actively traded, with some anticipating a rebound.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is trending downwards as investors react to news of the CEO selling shares, sparking concerns about the company's valuation and future prospects. Community discussions revolve around whether this is a buying opportunity or a sign of deeper issues, with some questioning the timing of the stock sale. Adding to the negative sentiment, comments about potential price cuts on weight-loss drugs are impacting the stock, overshadowing recent expansion into the menopause market.

Volatility Shares Trust - 2x Long VIX Futures ETF

Volatility Shares 2x Long VIX Futures ETF

UVIX is trending as traders discuss potential market volatility and its relationship to events like trade tensions and geopolitical issues. Community members are actively trading the ETF, with some building positions in anticipation of a spike, while others are focusing on short-term gains due to the ETF's decay. Concerns around market manipulation and the overall health of the economy are also fueling interest in this volatility product.

noice

The crypto asset NOICE is trending amid community excitement surrounding its recent listing on Coinbase and speculation about potential integration with X (Twitter).  Traders are closely watching key resistance levels and anticipating a breakout, while also discussing its low market cap as an attractive entry point. Some users are pointing to wallet dumping as a factor influencing price action.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Pharma stocks crack, Nifty Pharma Index slips over 2% as Trump unveils 100% tariff: 3 key factors investors must watch

… and patented drugs entering … pharma space include the likes of Natco Pharma , Laurus Labs, Alembic Pharma , Sun Pharma … , Gland Pharma , Ajanta Pharma , and Glenmark Pharmaceuticals … of Indian pharmaceutical exports. …

India's $30B Pharma Export Market Faces Heat from Trump's Tariff

… on branded and patented pharmaceuticals , as announced by President … on branded and patented pharmaceutical products beginning October 1, … Aurobindo Pharma , Zydus Lifesciences, Sun Pharma and Gland Pharma derive between … to make high-end drugs such as cancer and …

Healthcare stocks in India fell on Friday as investors weighed the impact of U.S. President Donald Trump’s move to impose a 100% tariff on branded and patented drugs starting Oct. 1.&nbsp;The measure, announced in late-night Truth Social posts, exempts only those manufacturers with U.S. plants that are already under construction or have broken ground.The Nifty Healthcare index fell 1.2% on Thursday, with 18 of its 20 components trading lower.&nbsp;IPCA Laboratories remained unchanged, while Torrent Pharma rose 0.01%.Analyst ViewSEBI-registered analyst&nbsp;<a href="https://stocktwits.com/ra_vishaltrehan">Vishal Trehan</a> said Gland Pharma is the most exposed, given its lack of a U.S. manufacturing footprint and reliance on branded or patented formulations.&nbsp;<stembedurl>https://stocktwits.com/ra_vishaltrehan/message/630078378</stembedurl>He noted that Syngene International, Piramal Pharma, and Zydus Lifesciences stand to benefit from their contract manufacturing models and biologics portfolios, which are less tariff-sensitive.Trehan also pointed out that companies with a large branded generics or biosimilars presence, such as Dr. Reddy’s Laboratories and Biocon, will need to accelerate U.S. production to avoid margin erosion.Trump’s Pharma TariffsThe announcement builds on Trump’s escalating trade measures aimed at repatriating drug manufacturing. Last month, he outlined a phased plan, beginning with a “small tariff” on imported drugs, before lifting duties to 150% within 18 months and ultimately to 250%.&nbsp;Pharmaceuticals had earlier been excluded from his reciprocal tariff program, but the new rules extend to prescription medicines, biologics, specialty drugs, and over-the-counter products, with generic drugs remaining exempt.What Is The Retail Mood?On Stocktwits, retail sentiment for Piramal Pharma, Zydus Lifesciences, and Dr. Reddy’s Laboratories was ‘bearish’ amid ‘normal’ message volume.So far this year,&nbsp;<a href="https://stocktwits.com/symbol/GLAND.NSE">Gland Pharma</a> has risen 6.5%, while&nbsp;<a href="https://stocktwits.com/symbol/SYNGENE.NSE">Syngene International</a> is down 29.1%,&nbsp;<a href="https://stocktwits.com/symbol/PPLPHARMA.NSE">Piramal Pharma</a> has slipped 25.9%,&nbsp;<a href="https://stocktwits.com/symbol/ZYDUSLIFE.NSE">Zydus Lifesciences</a> is up 1.8%,&nbsp;<a href="https://stocktwits.com/symbol/DRREDDY.NSE">Dr. Reddy’s Laboratories</a> is down 7.2%, and&nbsp;<a href="https://stocktwits.com/symbol/BIOCON.NSE">Biocon</a> has fallen 6.3%.For updates and corrections, email newsroom[at]stocktwits[dot]com.

India’s Healthcare Index Sinks After Trump’s Pharma Tariff Blow — SEBI Analyst Sees Risks For Gland, Biocon, Dr. Reddy’s

The analyst noted that Syngene, Piramal Pharma, and Zydus Lifesciences may be better positioned, as their contract manufacturing models and biologics portfolios are less susceptible to the tariff impact.

Equity

Business News | Trump's 100% Tariff on Patented Drugs Puts Spotlight on India's USD 30 Billion Pharma Export Market

… on branded and patented pharmaceutical products beginning October 1 … Aurobindo Pharma , Zydus Lifesciences, Sun Pharma and Gland Pharma derive … to make high-end drugs such as cancer … Company IS BUILDING their Pharmaceutical Manufacturing Plant in America. …

US President Donald Trump Announces Tariffs Up To 100% On Pharma, Starting October 1, 2025

India supplies over 45 per cent of generic and 15 per cent of biosimilar drugs used in the US. Firms like Dr Reddy's, Aurobindo Pharma, Zydus Lifesciences, Sun Pharma, and Gland Pharma reportedly earn anywhere from 30-50 per cent of their total revenues from the American market.

Why has US goverment given exemption to Indian pharmaceutical sector

The US granted a crucial exemption to India’s pharmaceutical industry from recent tariffs, recognizing the critical role of Indian generics in maintaining affordable healthcare. While initially a 50% tariff was imposed, the exemption protects the sector, preventing disruption to US drug access. Major Indian pharmaceutical players like Zydus Lifesciences, Dr. Reddy’s, Gland Pharma, and Biocon, heavily reliant on the US market, would be significantly impacted.

Gland Pharma Ltd. manufactures pharmaceutical ingredients and injectable formulations. It offers injectables including vials, ampoules, pre-filled syringes, lyophilized vials, dry powders, infusions, and ophthalmic solutions. The company was founded by P. V. N. Raju in 1978 and is headquartered in Sangareddy, India.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '25	13.67	--	--	N/A
Q1 '25	12.97	13.08	0.85%	BEAT
Q4 '24	12.21	--	--	N/A
Q3 '24	12.47	--	--	N/A
Q2 '24	11.30	--	--	N/A

GLAND.NSE
Gland Pharma Ltd.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q2 '25

Historical Earnings

Latest GLAND.NSE News

GLAND.NSEGland Pharma Ltd.